Milestone Scientific Amends Agreement to Enhance Financing Flexibility

The latest update is out from Milestone Scientific ( (MLSS) ).

On March 31, 2026, Milestone Scientific Inc. amended a previously executed Amended and Restated Memorandum of Understanding dated January 13, 2026 with Innovest S.p.A., which holds consent and blockage rights tied to BP4 S.r.l., then the reported owner of 11.31% of Milestone Scientific’s outstanding common shares. The amendment revises the definitions of “Qualified Offering” and “Other Locked-Up Parties” to ease restrictions and facilitate an offering by the company, potentially improving its ability to access capital markets and manage shareholder lock‑up arrangements.

These changes may streamline Milestone Scientific’s path to conducting future financings, as the redefined terms appear designed to reduce constraints imposed by BP4’s stake and Innovest’s consent rights. For stakeholders, the revised framework could expand the company’s financing flexibility and influence its capital structure, although full details of the amendment remain disclosed only in the referenced agreement.

The most recent analyst rating on (MLSS) stock is a Hold with a $0.29 price target. To see the full list of analyst forecasts on Milestone Scientific stock, see the MLSS Stock Forecast page.

Spark’s Take on MLSS Stock

According to Spark, TipRanks’ AI Analyst, MLSS is a Neutral.

The score is held back primarily by weak financial performance (ongoing losses, sustained cash burn, and a shrinking equity cushion). The latest earnings call adds moderate support via improved operating losses and upbeat 2026 growth guidance, but near-term liquidity and execution risk remain high. Technicals and valuation provide limited incremental support, with neutral momentum signals and a negative P/E due to continued losses.

To see Spark’s full report on MLSS stock, click here.

More about Milestone Scientific

Milestone Scientific Inc. is a company whose common stock is held in part by BP4 S.r.l., an entity in liquidation that reported owning 11.31% of Milestone Scientific’s outstanding shares. Innovest S.p.A. holds consent and blockage rights related to BP4’s stake, giving it influence over certain corporate and financing actions involving the company’s equity structure.

Average Trading Volume: 216,808

Technical Sentiment Signal: Sell

Current Market Cap: $24.02M

For detailed information about MLSS stock, go to TipRanks’ Stock Analysis page.